Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of the EyeControl Device (Eye-based Communication Device) for ALS Patients

NCT02891629 is registered in ClinicalTrials.gov with Eyefree Assisting Communication Ltd as lead sponsor.

NCT NCT02891629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02891629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of the EyeControl Device (Eye-based Communication Device) for ALS Patients
Lead sponsor
Eyefree Assisting Communication Ltd
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
February 28, 2017
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

als (amyotrophic lateral sclerosis)